Drug Trial Radar · NCT06193304
A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth
Last checked: Nov 20, 2026Latest source record: Jan 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6
Actual
Start
Aug 25, 2014
Primary completion
Sep 21, 2014
Study completion Sep 21, 2014
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jan 5, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A study to assess the absorption of eliglustat through the mouth in healthy subjects and the safety of any systemic exposure resulting from oral surface absorption of eliglustat in healthy subjects.
Conditions
- Gaucher's Disease
Interventions
EliglustatDrug
Pharmaceutical form:solution -Route of administration: Oral wihtout ingestion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Plasma pharmacokinetic (PK) parameter: CmaxTime frame: Multiple timepoints on Day 1
- Plasma pharmacokinetic (PK) parameter tmaxTime frame: Multiple timepoints on Day 1
- Plasma pharmacokinetic (PK) parameter AUClastTime frame: Multiple timepoints on Day 1
- Plasma pharmacokinetic (PK) parameter AUC 0-2hTime frame: Multiple timepoints on Day 1
- Plasma pharmacokinetic (PK) parameter AUC 2-4hTime frame: Multiple timepoints on Day 1
- Plasma pharmacokinetic (PK) parameter AUC 4-6hTime frame: Multiple timepoints on Day 1
- Plasma pharmacokinetic (PK) parameter tlastTime frame: Multiple timepoints on Day 1
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Covance Clinical Researsh Unit
Evansville, Indiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.